FibroBiologics Inc. Commo...

NASDAQ: FBLG · Real-Time Price · USD
0.57
-0.02 (-3.06%)
At close: Aug 15, 2025, 3:59 PM
0.57
-1.21%
After-hours: Aug 15, 2025, 05:55 PM EDT

FibroBiologics Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
13.98M 9.16M 2.27M 407K
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a
Receivables
n/a n/a 300K n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
18K 16K 30K 24K
Total Current Assets
14.23M 9.21M 2.63M 468K
Property-Plant & Equipment
2.22M 2.61M 2.2M n/a
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
2.22M 2.61M 2.2M n/a
Total Assets
16.45M 11.82M 4.82M 468K
Account Payables
2.7M 1.38M 493K 233K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
9.17M n/a 5.45M 1.52M
Other Current Liabilities
460K 7.44M 803K n/a
Total Current Liabilities
12.73M 9.18M 7.07M 1.76M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
984K 1.39M 1.75M n/a
Total Liabilities
13.71M 10.57M 8.82M 1.76M
Total Debt
10.55M 1.75M 7.52M 1.52M
Common Stock
n/a 1K 1K n/a
Retained Earnings
-35.52M -24.36M -7.87M -2.75M
Comprehensive Income
n/a n/a 1.46M 1.46M
Shareholders Equity
2.73M 1.25M -4M -1.29M
Total Investments
n/a n/a n/a n/a